Olympus Corporation to acquire Veran Medical Technologies in $340m deal
In a strategic move that positions Olympus Corporation as a dominant force in global medical devices, the Japanese…
Ensemble Orthopedics secures FDA clearance for innovative CMC implant for osteoarthritis treatment
Ensemble Orthopedics, a Texas-based medical device company, has secured 510(k) clearance from the US Food and Drug Administration…
Novo Nordisk secures FDA approval for Saxenda label update targeting adolescent obesity treatment
Novo Nordisk, a global leader in diabetes and obesity care, has received approval from the US Food and…
Bioniz Therapeutics reports positive phase 1/2 trial data for BNZ-1 in treating relapsed/refractory CTCL
Bioniz Therapeutics, a leading player in the field of peptide-based therapeutics, has revealed promising data from a phase…
WCG acquires Trifecta Clinical to enhance clinical trial solutions and efficiency
In a significant move aimed at transforming the clinical trials landscape, WCG, a US-based clinical services company, has…
Janssen acquires HMR59 from Hemera for geographic atrophy treatment
Janssen Pharmaceuticals has secured the rights to an innovative gene therapy, HMR59, for the treatment of geographic atrophy,…
Appili Therapeutics begins Phase 3 clinical trial for Avigan in fight against Covid-19
Appili Therapeutics, a Canadian infectious disease biopharmaceutical company, has announced a major milestone in its fight against Covid-19:…
UK grants emergency authorization for Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted emergency use authorization (EUA) for the BNT162b2…
Sedana Medical seeks approval for Sedaconda in Europe, eyes inhaled sedation for ICU patients
Sedana Medical, a prominent player in the field of medical sedatives, has officially submitted an application for regulatory…
Sage Therapeutics strikes $3.1bn licensing deal with biogen for depression and neurological disorder treatments
Sage Therapeutics has entered into a high-stakes global collaboration and licensing agreement with Biogen, valued at up to…